KDL(SH:603987)2022-04-25 16:00Financial Performance - The company's operating revenue for Q1 2022 reached ¥867,498,005.94, representing a year-on-year increase of 28.81%[3] - The net profit attributable to shareholders was ¥70,885,812.12, reflecting a significant growth of 55.67% compared to the same period last year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥62,455,086.33, an increase of 39.99% year-on-year[3] - Basic and diluted earnings per share were both ¥0.16, marking a 60.00% increase from the previous year[3] - Net profit for Q1 2022 was ¥103,563,725.82, representing a 54% increase compared to ¥67,212,725.38 in Q1 2021[16] - The company's equity attributable to shareholders increased to ¥2,153,316,095.82 in Q1 2022, up from ¥2,077,359,146.68 in Q1 2021, a growth of 3.7%[14] - The company reported a comprehensive income total of ¥100,611,430.72 for Q1 2022, compared to ¥67,249,525.29 in Q1 2021, an increase of 49.8%[17] Cash Flow and Liquidity - The net cash flow from operating activities was ¥3,112,481.68, showing a remarkable increase of 105.85%[3] - In Q1 2022, the cash inflow from operating activities totaled approximately $846.23 million, an increase of 27.06% compared to $666.10 million in Q1 2021[20] - The net cash flow from operating activities was $3.11 million, a significant improvement from a net outflow of $53.20 million in the same quarter of the previous year[20] - The total cash and cash equivalents at the end of Q1 2022 stood at $868.18 million, compared to $724.31 million at the end of Q1 2021, showing an increase of 19.88% year-over-year[21] - The company experienced a net decrease in cash and cash equivalents of $130.24 million in Q1 2022, compared to a decrease of $497.74 million in Q1 2021, showing improved cash management[21] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥5,411,810,380.62, up 9.15% from the end of the previous year[3] - The company's total assets increased to ¥5,411,810,380.62 in Q1 2022, up from ¥4,957,926,694.14 in Q1 2021, marking a growth of 9.1%[14] - Total liabilities rose to ¥1,895,881,947.23 in Q1 2022, compared to ¥1,567,963,215.51 in Q1 2021, reflecting a 20.9% increase[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 22,406[8] - The company reported a total of 151,909,010 shares held by its largest shareholder, Shanghai Kangdelai Holdings Group Co., Ltd.[10] - The top ten shareholders include various investment funds, with the largest being China Construction Bank's Guotai Health Fund holding 16,140,703 shares[10] Operational Insights - The company emphasized the expansion of production capacity and improvement in product quality as key drivers for the strong performance in Q1 2022[4] - The company plans to continue investing in capital to seek new growth points for future performance[4] - The company has not disclosed any significant new product developments or market expansion strategies during the reporting period[11] - There were no significant mergers or acquisitions reported in the latest earnings call[11] Research and Development - Research and development expenses for Q1 2022 were ¥36,541,940.12, slightly up from ¥35,290,634.31 in Q1 2021[16]